Bio-Rad Laboratories (BIO) Insider Trading & Ownership $226.75 -0.86 (-0.38%) As of 03:59 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Bio-Rad Laboratories (NYSE:BIO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage17.06%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$1.30 M Get BIO Insider Trade Alerts Want to know when executives and insiders are buying or selling Bio-Rad Laboratories stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BIO Insider Buying and Selling by Quarter Bio-Rad Laboratories Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/6/2024Andrew J LastCOOSell3,000$329.94$989,820.00 9/4/2024James BarryEVPSell623$330.49$205,895.27 6/13/2024Michael CrowleyEVPSell369$281.91$104,024.79 (Data available from 1/1/2013 forward) BIO Insider Trading Activity - Frequently Asked Questions Who is on Bio-Rad Laboratories's Insider Roster? The list of insiders at Bio-Rad Laboratories includes Ajit Ramalingam, Andrew J Last, Dara Wright, James Barry, Michael Crowley, and Timothy S Ernst. Learn more on insiders at BIO. What percentage of Bio-Rad Laboratories stock is owned by insiders? 17.06% of Bio-Rad Laboratories stock is owned by insiders. Learn more on BIO's insider holdings. Which Bio-Rad Laboratories insiders have been selling company stock? The following insiders have sold BIO shares in the last 24 months: Ajit Ramalingam ($72,923.40), Andrew J Last ($989,820.00), Dara Wright ($358,992.00), James Barry ($205,895.27), Michael Crowley ($1,497,593.99), and Timothy S Ernst ($1,045,067.00). How much insider selling is happening at Bio-Rad Laboratories? Insiders have sold a total of 12,182 Bio-Rad Laboratories shares in the last 24 months for a total of $4,170,291.66 sold. Bio-Rad Laboratories Key ExecutivesMr. Norman D. Schwartz (Age 74)Chairman, CEO & President Compensation: $1.25MDr. Andrew J. Last Ph.D. (Age 64)Executive VP & COO Compensation: $682.29kMr. Roop K. Lakkaraju (Age 53)Executive VP & CFO Ms. Tania DeVilliers (Age 50)Senior Director, Corporate Controller & Interim Principal Accounting Officer Mr. Yong ChungVice President of Investor RelationsMatthew WernerSenior Vice President and Chief Compliance & Privacy OfficerCourtney C. EnloeExecutive VP, General Counsel & SecretaryMs. Colleen Corey (Age 62)Executive Vice President of Global Human Resources Mr. Michael Crowley (Age 62)Executive Vice President of Global Commercial Operations Compensation: $974.94kLee BoydSenior Vice President of Global Commercial Operations - Asia Pacific More Insider Trading Tools from MarketBeat Related Companies MTD Insider Transactions WAT Insider Transactions ILMN Insider Transactions TECH Insider Transactions CRL Insider Transactions BRKR Insider Transactions PACB Insider Transactions HBIO Insider Transactions TMO Insider Transactions A Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Dividend Investors Looking for an Edge? 3 Stocks Insiders BoughtMeta's Institutional & Insider Data Fuels Bulls Despite DisparityTurbulence for Joby Shares: What's Behind the Recent Dip?UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?Sprouts Stock: Insider Sales, But Strong Bullish Signals This page (NYSE:BIO) was last updated on 5/30/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredTrump Just Gave the Green Light to Rewrite Social Security?In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredHISTORIC Gold Move Sends Flashing Red Signal To 401K SaversHistorically, when panic hits Wall Street, investors rush to raise cash to cover their leveraged positions be ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Rad Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
